Precision BioSciences, Inc. (DTIL) Q1 2024 Earnings
DTIL·Reported May 13, 2024·Before market open
Precision BioSciences, Inc. reported Q1 2024 revenue of $17.6M, beat analyst consensus of $6.0M by $11.6M. Diluted EPS came in at $-0.35, beat the $-0.45 consensus by $0.10.
Revenue
$17.6Mbeat by $11.6M
Consensus: $6.0MDiluted EPS
$-0.35beat by $0.10
Consensus: $-0.45
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Precision BioSciences, Inc.'s Q1 2024 earnings report.
Precision BioSciences, Inc. (DTIL) reported Q1 2024 earnings on May 13, 2024 before market open.
Precision BioSciences, Inc. reported revenue of $17.6M and diluted EPS of $-0.35 for Q1 2024.
Revenue beat the consensus estimate of $6.0M by $11.6M. EPS beat the consensus estimate of $-0.45 by $0.10.
You can read the 10-Q periodic report (0000950170-24-058192) directly on SEC EDGAR. The filing index links above go to sec.gov.